Rehospitalization After AMI Linked to Worse Health Status

This article originally appeared here.
Share this content:
Rehospitalization After AMI Linked to Worse Health Status
Rehospitalization After AMI Linked to Worse Health Status

THURSDAY, Oct. 27, 2016 (HealthDay News) -- For patients after acute myocardial infarction, rehospitalization for unstable angina (UA) and unplanned revascularization during the first year are associated with worse health status, according to a study published online Oct. 25 in Circulation: Cardiovascular Quality and Outcomes.

Supriya Shore, M.D., from the Emory University School of Medicine in Atlanta, and colleagues assessed health status for 3,283 patients with acute myocardial infarction enrolled in a prospective, 24-center U.S. study who had rehospitalizations. In propensity-matched cohorts, one-year health status was compared for those who did and did not experience rehospitalization for UA or revascularization.

The researchers found that at one year, the rehospitalization rates for UA and unplanned revascularization were 4.3 and 4.7 percent, respectively. Compared with patients without rehospitalizations, those with rehospitalizations for UA and unplanned revascularization had worse one-year Seattle Angina Questionnaire summary scores (mean difference, −10.1 and −5.7, respectively). The EuroQol-5D Visual Analog Scale scores were also worse with rehospitalizations. Among patients rehospitalized for UA or unplanned revascularization, worse one-year angina and quality-of-life outcomes were seen with individual Seattle Angina Questionnaire domains.

"These findings highlight the impact of such events from a patient's perspective, beyond their economic impact, and support the use of UA and unplanned revascularization as elements of composite end points," the authors write.

Several authors disclosed financial ties to medical device and pharmaceutical companies, including Eli Lilly, which provided funding for the study; one author owns the copyright to the Seattle Angina Questionnaire.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »